TY - GEN 
AU - Tuta-Quintero E.
AU - Perna-Reyes I.
AU - Olivella-Gómez J.
AU - Rodríguez-Fraile D.
AU - Santacruz J.C.
AU - Mayorga-Borja A.A.
AU - Londoño J.
PY - 2024
SN - 1218123
UR - http://hdl.handle.net/10818/62789
AB - Mepolizumab (MPZ) is a therapeutic option for eosinophilic granulomatosis with polyangiitis (EGPA). However, the evidence on its efficacy, effectiveness, and safety is limited. Our results included 17 full-text articles evaluating the use of MPZ in...
LA - eng
PB - Revista Colombiana de Reumatologia
KW - Effectiveness
KW - Efficacy
KW - Mepolizumab
KW - Safety
KW - Systematic review
TI - Therapeutic evidence of mepolizumab in eosinophilic granulomatosis with polyangiitis: A scoping review
DO - 10.1016/j.rcreu.2023.11.003
ER -